4.04 USD
+0.32 (+8.6%)
4.02 USD
-0.02 (-0.5%)
ChartMill assigns a Buy % Consensus number of 86% to ZURA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.32. This target is 303.96% above the current price.
ZURA was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ZURA.
In the previous month the buy percentage consensus was at a similar level.
ZURA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-13 | Clear Street | Initiate | Buy |
| 2025-09-30 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-19 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-08-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-03-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-26 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-24 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-04 | Leerink Partners | Initiate | Outperform |
| 2024-10-21 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-10-18 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-09-05 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-08-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-12 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-03 | Piper Sandler | Initiate | Overweight |
| 2024-04-01 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-10-10 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-25 | Oppenheimer | Initiate | Outperform |
| 2023-08-15 | Raymond James | Maintains | Strong Buy -> Strong Buy |
ZURA BIO LTD / ZURA FAQ
Can you provide the average price target for ZURA BIO LTD stock?
13 analysts have analysed ZURA and the average price target is 16.32 USD. This implies a price increase of 303.96% is expected in the next year compared to the current price of 4.04.
Can you provide the consensus rating for ZURA BIO LTD stock?
The consensus rating for ZURA BIO LTD (ZURA) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover ZURA BIO LTD (ZURA) stock?
The number of analysts covering ZURA BIO LTD (ZURA) is 13.